101 related articles for article (PubMed ID: 4374264)
1. Nasopharyngeal carcinoma. VII. B and T lymphocytes in the circulating blood and in tumour tissue.
Yata J; Desgranges C; De-Thé G; Mourali N; Ellouz R; Tachibana T; Brugere J
Biomedicine; 1974 Jun; 21(6):244-50. PubMed ID: 4374264
[No Abstract] [Full Text] [Related]
2. Use of immunological studies in evaluating the clinical course of nasopharyngeal carcinoma.
Sawaki S; Kawamura A; Tachibana T
IARC Sci Publ (1971); 1978; (20):575-85. PubMed ID: 215534
[TBL] [Abstract][Full Text] [Related]
3. Serum anti-EBV IgA is inversely related to tumor infiltration by surface IgA positive lymphocytes in nasopharyngeal carcinoma.
Gunvén P; Klein G; Henle W; Henle G; Forsby N
Biomed Pharmacother; 1983; 37(1):41-4. PubMed ID: 6311307
[TBL] [Abstract][Full Text] [Related]
4. Classification of lymphocytes in nasopharyngeal carcinoma (NPC) biopsies.
Jondal M; Klein G
Biomedicine; 1975 Jun; 23(5):163-5. PubMed ID: 1081410
[TBL] [Abstract][Full Text] [Related]
5. [The cytotoxic effect of lymphocytes from patients with nasopharyngeal cancer (NPC) against a NPC epitheloid cell line (author's transl)].
Lin YC; Chao WP; Liu CR; Hu RL; Zeng Y
Zhonghua Zhong Liu Za Zhi; 1981 Feb; 3(1):1-4. PubMed ID: 6273085
[No Abstract] [Full Text] [Related]
6. [Anti-complement immunoperoxidase technique in the determination of EBNA antibody level in patients with nasopharyngeal carcinoma (author's transl)].
Liu YX
Zhonghua Zhong Liu Za Zhi; 1982 Feb; 4(1):20-2. PubMed ID: 6284464
[No Abstract] [Full Text] [Related]
7. Herpes viruses and oncogenesis.
Klein G
Johns Hopkins Med J Suppl; 1974; 3():15-25. PubMed ID: 4370988
[No Abstract] [Full Text] [Related]
8. Cellular immunity in nasopharyngeal carcinoma. III. Lymphocyte subpopulations and lymphocyte response to phytohemagglutinin.
Hsu MM; Wang KR; Lynn TC; Hsieh T; Tu SM
Taiwan Yi Xue Hui Za Zhi; 1978 Jul; 77(7):549-55. PubMed ID: 308994
[No Abstract] [Full Text] [Related]
9. Distribution of T- and B-cells and of immunoglobulin-producing cells in tumor tissue of patients with nasopharyngeal carcinoma.
Konorza G; Sesterhenn K; Krueger GR; Ablashi DV
J Cancer Res Clin Oncol; 1979 Feb; 93(2):195-204. PubMed ID: 220268
[TBL] [Abstract][Full Text] [Related]
10. B lymphocytopenia in infectious mononucleosis.
Sumaya CV; Keightley RG
Clin Exp Immunol; 1981 Feb; 43(2):298-301. PubMed ID: 6268336
[TBL] [Abstract][Full Text] [Related]
11. [A modified 131 I immuno-autoradiographic method for detection of serum EB virus VCA-IgA antibody in nasopharyngeal carcinoma].
Shang M
Zhonghua Zhong Liu Za Zhi; 1982 Nov; 4(4):262-4. PubMed ID: 6299669
[No Abstract] [Full Text] [Related]
12. General immunological status of nasopharyngeal carcinoma patients in Singapore.
Chan SH; Goh EH; Khor TH; Chew TS
IARC Sci Publ (1971); 1978; (20):495-501. PubMed ID: 215531
[TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus-related lymphocyte stimulation inhibitor: a possible prognostic tool for undifferentiated nasopharyngeal carcinoma.
Kamaraju LS; Levine PH; Sundar SK; Ablashi DV; Faggioni A; Armstrong GR; Bertram G; Krueger GR
J Natl Cancer Inst; 1983 Apr; 70(4):643-7. PubMed ID: 6300502
[TBL] [Abstract][Full Text] [Related]
14. [Distribution of EBV-VCA and EA antibody in the general population in a high incidence area of nasopharyngeal carcinoma].
Liu YX
Zhonghua Zhong Liu Za Zhi; 1983 Sep; 5(5):337-9. PubMed ID: 6317314
[No Abstract] [Full Text] [Related]
15. [Investigation of 2 families with clustering of nasopharyngeal carcinoma and detection of serum VCA-IgA antibody among their members].
Tang ZH
Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):553-5. PubMed ID: 6317146
[No Abstract] [Full Text] [Related]
16. [Symptomatologic value of the assay of EBV antibodies in carcinoma of the nasopharynx].
de Thé G
J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1983 Oct; 32(8):493-9. PubMed ID: 6319536
[No Abstract] [Full Text] [Related]
17. Studies on nasopharyngeal carcinoma in Thailand.
Premabutr P; Thomson S; Srivatanakul P
J Med Assoc Thai; 1974 Apr; 57(4):191-6. PubMed ID: 4377011
[No Abstract] [Full Text] [Related]
18. Epstein-Barr virus-associated antibodies and serum biochemistry in nasopharyngeal carcinoma.
Lynn TC; Hsieh RP; Chuang CY; Huang SC; Hsieh T; Tu SM
Laryngoscope; 1984 Nov; 94(11 Pt 1):1485-8. PubMed ID: 6092804
[TBL] [Abstract][Full Text] [Related]
19. [Detection of early NPC from VCA/IgA antibody positive individuals with anticomplement immunoenzymatic method].
Zeng Y; Shen SJ; Deng H; Ma JL; Zhang Q; Zhu JS; Cheng JR
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Aug; 4(4):254-5. PubMed ID: 6295651
[No Abstract] [Full Text] [Related]
20. Epstein-Barr virus is not associated with head and neck neoplasms other than nasopharyngeal carcinoma.
Kottaridis SD; Goula I; Kiparissiadis P
Neoplasma; 1982; 29(3):327-31. PubMed ID: 6290911
[No Abstract] [Full Text] [Related]
[Next] [New Search]
